| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Artificial intelligence for diabetes care: current and future prospects
|
Sheng, Bin
|
|
|
12 |
8 |
p. 569-595
|
artikel
|
| 2 |
Association of glycaemic index and glycaemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality
|
Reynolds, Andrew
|
|
|
12 |
8 |
p. 515-516
|
artikel
|
| 3 |
Association of glycaemic index and glycaemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality – Authors' reply
|
Jenkins, David J A
|
|
|
12 |
8 |
p. 516-518
|
artikel
|
| 4 |
Association of glycaemic index and glycaemic load with type 2 diabetes in the PURE study
|
Reynolds, Andrew
|
|
|
12 |
8 |
p. 518-519
|
artikel
|
| 5 |
Association of glycaemic index and glycaemic load with type 2 diabetes in the PURE study – Authors' reply
|
Miller, Victoria
|
|
|
12 |
8 |
p. 519
|
artikel
|
| 6 |
Call for effective therapies for preventing dementia in people with type 2 diabetes
|
van Sloten, Thomas T
|
|
|
12 |
8 |
p. 510-513
|
artikel
|
| 7 |
Early pregnancy HbA1c as the first screening test for gestational diabetes: results from three prospective cohorts
|
Saravanan, Ponnusamy
|
|
|
12 |
8 |
p. 535-544
|
artikel
|
| 8 |
Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials
|
Apperloo, Ellen M
|
|
|
12 |
8 |
p. 545-557
|
artikel
|
| 9 |
Impact of higher BMI on cardiometabolic risk: does height matter?
|
Stefan, Norbert
|
|
|
12 |
8 |
p. 514-515
|
artikel
|
| 10 |
Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million people
|
Taylor, Kurt
|
|
|
12 |
8 |
p. 558-568
|
artikel
|
| 11 |
Once-weekly semaglutide in people with HIV-associated lipohypertrophy: a randomised, double-blind, placebo-controlled phase 2b single-centre clinical trial
|
Eckard, Allison Ross
|
|
|
12 |
8 |
p. 523-534
|
artikel
|
| 12 |
Precision nutrition: a step too far?
|
The Lancet Diabetes & Endocrinology,
|
|
|
12 |
8 |
p. 503
|
artikel
|
| 13 |
Semaglutide in people with HIV-associated lipohypertrophy
|
Hwang, Y Joseph
|
|
|
12 |
8 |
p. 504-505
|
artikel
|
| 14 |
Semaglutide: weighing up the benefits and risks
|
Moody, Joe
|
|
|
12 |
8 |
p. 520
|
artikel
|
| 15 |
SGLT2 inhibitors and GLP-1 receptor agonists: the definitive combination?
|
Escobar Cervantes, Carlos
|
|
|
12 |
8 |
p. 507-508
|
artikel
|
| 16 |
The deep pockets of health-harming industries
|
Burki, Talha
|
|
|
12 |
8 |
p. 521-522
|
artikel
|
| 17 |
The enduring effect of the COVID-19 pandemic on diabetes
|
Al-Aly, Ziyad
|
|
|
12 |
8 |
p. 508-510
|
artikel
|
| 18 |
The potential role for artificial intelligence in fracture risk prediction
|
Hong, Namki
|
|
|
12 |
8 |
p. 596-600
|
artikel
|
| 19 |
Value of early pregnancy HbA1c to predict gestational diabetes
|
Gupta, Yashdeep
|
|
|
12 |
8 |
p. 505-507
|
artikel
|
Tijdschrift beschrijving